Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes (Q45190512)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 October 2015
edit
Language Label Description Also known as
English
Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes
scientific article published on 20 October 2015

    Statements

    Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes (English)
    Robert R Henry
    Payal Thakkar
    Cindy Tong
    David Polidori
    Maria Alba
    20 October 2015
    2258-2265

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit